Symbols

Symbols

RLAY

RLAY

Relay Therapeutics: Wells Fargo Maintains Equal-Weight, PT Raised to $6 from $4.

Thursday Nov 06, 2025

Relay Therapeutics Reports Q3 2025 Financial Results, Appoints Board Members

Tuesday Nov 04, 2025

RLAY CEO Patel Sanjiv Sells 62073 Shares at $7/Share on Nov 3, 2023.

Monday Nov 03, 2025

Relay Therapeutics to Participate in Two Investor Conferences in November

Thursday Oct 30, 2025

Relay Therapeutics Executives Sell Shares Amid Recent Price Surge

Wednesday Oct 29, 2025

Relay Therapeutics: Bollinger Bands Expanding Downward, KDJ Death Cross Triggered.

Monday Oct 27, 2025

Relay Therapeutics: Bollinger Bands Narrowing, KDJ Death Cross on 15min Chart

Friday Oct 24, 2025

Relay Therapeutics Sees Bullish Momentum with KDJ Golden Cross, Bullish Marubozu.

Relay Therapeutics: A Promising Precision Oncology Company

Relay Therapeutics: MACD Death Cross, Bearish Marubozu on 15-minute chart.

Thursday Sep 04, 2025

Guggenheim Assumes Buy Rating on Relay Therapeutics with PT of $15

Relay Therapeutics shares rise 2.19% premarket after former CLO Brian Adams appointed as Kymera Therapeutics' Chief Legal Officer.

Wednesday Sep 03, 2025

Relay Therapeutics shares rise 2.19% after-hours following Brian Adams' appointment as Kymera Therapeutics' Chief Legal Officer.

Friday Aug 29, 2025

Relay Therapeutics shares fall 3.04% intraday as management prepares for upcoming fireside chats.

Tuesday Aug 26, 2025

Relay Therapeutics shares fall 1.28% intraday after HC Wainwright adjusts price target.

Relay Therapeutics: HC Wainwright Maintains Buy, PT Down to $14 from $16.

Tuesday Aug 19, 2025

Relay Therapeutics shares fall 2.45% intraday as Piper Sandler initiates coverage on Bicara Therapeutics.

Tuesday Aug 12, 2025

Relay Therapeutics (RLAY) Receives Buy Rating from Leerink Partners with $12.00 Price Target

Sunday Aug 10, 2025

Raymond James Keeps 'Strong Buy' Rating on Relay Therapeutics but Lowers Price Target to $19

Friday Aug 08, 2025

Relay Therapeutics: Raymond James Maintains Strong Buy, PT Down to $19.